Navigation Links
Cancer Antibodies: Drug Target Atlas and Competitive Outlook
Date:11/15/2012

9.160 PROBIOMED 20659.161 ProCell Therapeutics 20729.162 Prochon Biotech 20769.163 Progenics Pharmaceuticals 20829.164 Ramot 20879.165 Recepta biopharma 20919.166 Receptor BioLogix 20959.167 Regeneron 21019.168 Sanofi 21109.169 SBI Biotech 21169.170 Scancell 21219.171 Seattle Genetics 21259.172 Shanghai CP Guojian 21369.173 Shenogen 21469.174 Stainwei Biotech 21509.175 Sunol Molecular 21569.176 SuppreMol 21619.177 Switch Pharma 21669.178 Symphogen 21709.179 Synageva BioPharma 21789.180 SynerGene Therapeutics 21889.181 Tactic Pharma 21929.182 Takeda 21969.183 Tamir Biotechnology 22029.184 Targa Therapeutics 22079.185 TeGenero 22159.186 Teva 22199.187 ThromboGenics 22269.188 Titan Pharmaceuticals 22319.189 Tolerx 22379.190 Tracon Pharmaceuticals 22429.191 Transgene 22479.192 Trillium Therapeutics 22529.193 Trion Pharma 22569.194 UCB 22649.195 United Therapeutics 22709.196 Vaccinex 22749.197 VasGene Therapeutics 22839.198 Viragen 22879.199 Viventia Biotech 22939.200 Wakunaga 22979.201 Wilex 23039.202 XBiotech 23079.203 Xencor 23129.204 Xerion 23319.205 Xoma 23379.206 Y's Therapeutics 23439.207 YM BioSciences 23479.208 Zenotech 235410 Disclaimer 2361

1.1 List of Figures

Figure 1: Visualization of Target-Target Interactions among Targets of Antibody Drugs in Cancer 371

Figure 2: The Drug-Target Competitive Landscape of Antibody Drugs in Cancer - Large Cluster 376

Figure 3: The Drug-Target Competitive Landscape Antibody Drugs in Cancer - Smaller Clusters 1(2) 377

Figure 4: The Drug-Target Competitive Landscape Antibody Drugs in Cancer - Smaller Clusters 2(2) 378

Figure 5: Head-to-Head Targeting Competitive Landscape of Antibody Drugs in Cancer - 1 (2) 379

Figure 6: Head-to-Head Targeting Competitive Landscape of Antibody Drugs in Cancer - 2 (2) 380

Figure 7: Number of Companies per Ranking Level 917

1.2 List of Tables

Table 1: Cancer Highlights'™ Five Pillar Drug Assessment 7Table 2: Breakdown of the In
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
2. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
3. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
4. NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
5. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
6. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
7. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
8. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
9. New research points to benefits of innovative cobasĀ® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
10. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
11. US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... 29, 2014 Second generation biofuels are a ... fossil fuels. However, as natural gas is very cheap, this ... are not as valuable as they could be in comparison ... financing projects, has made it difficult for renewable energy developers ... off the ground. For these reasons, certain companies have shifted ...
(Date:7/29/2014)... July 29, 2014 A new ... market (types, applications and geography) - Size, Share, Global ... Segmentation and Forecast, 2013 - 2020", suggests that the ... billion by 2020 registering a CAGR of 11.1% from ... achieved by the electro surgical devices in operative procedures ...
(Date:7/29/2014)... & Rockville, MD (PRWEB) July 29, 2014 ... Inc. (ITI), a vaccine pioneer in the biotechnology ... services firm Newport Coast Securities, Inc. to explore ... is commercializing LAMP-vax technology, a breakthrough vaccine platform ... and immunotherapy market. The company exclusively licensed the ...
(Date:7/29/2014)... Carolina (PRWEB) July 29, 2014 DisasterTalk is ... of people where cell phone masts or other transmitters are ... to 100 feet away without the need for any Wi-Fi, ... longer ranges. , The new app has launched as a ... homes are at very high risk of being affected by ...
Breaking Biology Technology:Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3DisasterTalk App Could Save Lives as Report Reveals 8% of US Homes at Very High Risk of Natural Disaster 2
... Additional Phase 3 Trials on Track for Initiation Later ... for Today at 8:30 a.m. Eastern Time -, ... ARNA ) announced today that an independent Echocardiographic,Data Safety ... to stop,the ongoing pivotal Phase 3 trial, BLOOM (Behavioral ...
... Unit for $185 Million; Deal ... Expected to Close in the Fourth Quarter 2007, ... NABI ) announced today that it has entered into,a ... the Nabi,Biologics strategic business unit (SBU) to Biotest Pharmaceuticals,Corporation ...
... Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) ... 8:30 a.m. EDT to discuss the,Phase IIb clinical trial ... was initiated yesterday. Hosting the call will be ... will be two distinguished members of the diabetic,neuropathic pain ...
Cached Biology Technology:Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 2Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 3Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 4Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 5Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review 6Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG 2Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG 3Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG 4Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG 5Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG 6Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain 2
(Date:7/29/2014)... Francisco is the first to show that while the ... aging, these negative effects may be reduced by maintaining ... "The study participants who exercised, slept well and ate ... didn,t maintain healthy lifestyles, even when they had similar ... assistant professor in the department of psychiatry at UCSF. ...
(Date:7/28/2014)... An international team of researchers led by the University ... rice. , The genetic information will enhance scientists, and ... as well as enable the development of new rice ... environmental stressors to help solve global hunger challenges. , ... Oryza glaberrima ) and evidence for independent domestication," was ...
(Date:7/28/2014)... School of Medicine have pinpointed a mechanism in part of ... the blood, linking it to both type 1 and type ... issue of Proceedings of the National Academies of Sciences ... located in a part of the hypothalamus known as ... motion that control glucose levels in the blood," said lead ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Glucose 'control switch' in the brain key to both types of diabetes 2
... University Park, Pa. Health benefits from polyphenol antioxidants ... may come at a cost to some people. Penn ... the amount of iron the body absorbs, which can ... "Polyphenols have been known to have many beneficial effects ...
... biological invader that reaches its shores via cargo shipped ... Asian Longhorned Beetles, Kudzu, Triffid weed and others have ... harming human health and threatening biodiversity. The answer: ... of controlling invaders against the economic necessity of free ...
... brings debilitating side effects such as nausea, liver toxicity and ... way to deliver this life-saving therapy to cancer patients ― ... been invented by Dr. Dan Peer of Tel Aviv University,s ... Nano Science and Nano Technology together with Prof. Rimona Margalit ...
Cached Biology News:Polyphenol antioxidants inhibit iron absorption 2New analysis weighs lost trade, costs to control invasive species against economic damages 2New analysis weighs lost trade, costs to control invasive species against economic damages 3A cluster bomb for cancer care 2
US Pharmacopoeia Purified-Water/Water-for-Injection Quality Water...
... PinPoint™ Vector Sequencing Primer is designed for ... Vectors (Cat.# V2031, V2051, V2061). The primer ... at nucleotides 325343, approximately 4050 base pairs ... can be used to determine if an ...
Request Info...
...
Biology Products: